Alpha Cognition Inc. Common Stock
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACOG research report →
Companywww.alphacognition.com
Alpha Cognition Inc. , a clinical stage biopharmaceutical company, engages in the development of treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). The company offers ZUNVEYL (benzgalantamine) for the treatment of mild-to-moderate Alzheimer's disease and mild traumatic brain injury.
- CEO
- Michael E. McFadden
- IPO
- 2024
- Employees
- 5
- HQ
- Vancouver, BC, CA
Price Chart
Valuation
- Market Cap
- $94.43M
- P/E
- -5.26
- P/S
- 8.72
- P/B
- 2.30
- EV/EBITDA
- -1.49
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 86.36%
- Op Margin
- -250.06%
- Net Margin
- -232.24%
- ROE
- -54.13%
- ROIC
- -42.41%
Growth & Income
- Revenue
- $10.22M · 0.00%
- Net Income
- $-20,669,875 · -41.22%
- EPS
- $-1.17 · 42.08%
- Op Income
- $-22,660,689
- FCF YoY
- -165.65%
Performance & Tape
- 52W High
- $11.54
- 52W Low
- $4.50
- 50D MA
- $6.07
- 200D MA
- $6.57
- Beta
- 2.39
- Avg Volume
- 58.38K
Get TickerSpark's AI analysis on ACOG
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 19, 26 | D'Angelo Lauren | buy | 3,500 |
| May 18, 26 | Opaleye Management Inc. | buy | 17,395 |
| May 15, 26 | Opaleye Management Inc. | buy | 16,648 |
| Apr 16, 26 | Sensenig Bethany | other | 6,991 |
| Apr 16, 26 | Sensenig Bethany | other | 5,489 |
| Apr 15, 26 | Sensenig Bethany | other | 0 |
| Mar 30, 26 | Opaleye Management Inc. | buy | 1,850 |
| Mar 27, 26 | Opaleye Management Inc. | buy | 10,000 |
| Mar 26, 26 | Opaleye Management Inc. | buy | 7,319 |
| Mar 25, 26 | Opaleye Management Inc. | buy | 8,581 |
Our ACOG Coverage
We haven't published any research on ACOG yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ACOG Report →